Related Experiment Videos

[Hepatocytes growth factor (HGF), leptin, neopterin serum concentrations in patients with chronic hepatitis C]

K Zwirska-Korczala1, A P Dziambor, A Wiczkowski

  • 1Katedra i Zakład Fizjologii w Zabrzu Slaskiej Akademii Medycznej w Katowicach.

Insights

In patients with chronic hepatitis C, elevated serum leptin, HGF, and neopterin levels were observed. These biomarkers may indicate liver inflammation and damage severity in hepatitis C patients.

Area of Science:

  • Biochemistry
  • Immunology
  • Hepatology

Context:

  • Chronic hepatitis C is a significant global health concern.
  • Assessing liver inflammation and damage is crucial for patient management.
  • Biomarkers can offer insights into disease activity and progression.

Purpose:

  • To evaluate serum concentrations of leptin, hepatocyte growth factor (HGF), and neopterin in patients with chronic hepatitis C.
  • To determine the correlation between these biomarkers and indicators of liver disease severity, including inflammatory grading, fibrosis staging, and GGTP activity.

Summary:

  • Serum concentrations of leptin, HGF, and neopterin were significantly higher in 18 chronic hepatitis C patients compared to controls.
  • Leptin levels correlated with liver biopsy inflammatory grading.
  • HGF concentrations were associated with fibrosis staging, while neopterin correlated with both inflammatory and fibrosis parameters, as well as GGTP activity.

Impact:

  • Increased neopterin may indicate active liver inflammation.
  • Leptin and HGF serum levels could serve as indicators of liver damage intensity in chronic hepatitis C.
  • These findings suggest potential utility of these biomarkers in monitoring hepatitis C progression and treatment response.
Abstract

Related Concept Videos